Final Itinerary [view]

Programme Highlights
  • Advances In Radiotherapy | How Many Brain Lesions Can We Now SRS?

  • Novel Agents In Radiation Biology | Bioreductives And DNA Repair Inhibitors To Improve Radiotherapy Response In Breast Cancer

  • Contemporary Role Of Axillary Surgery Post Sentinel-Node Biopsy In Breast Cancer

  • Crossing The Blood-Brain Barrier : Systemic Therapies In Breast Cancer With Brain And Leptomeningeal Metastases

  • Utility Of PET-CT In Clinical Oncology And Cancer Research

  • Systemic Management Of Metastatic Soft Tissue Sarcoma And Novel Agents

  • Novel Promising Agents For Nasopharyngeal Carcinoma And Potential Biomarkers

  • How Artificial Intelligence Changes Medical Imaging Diagnostic?

  • Systemic Management Of Metastatic Radioiodine Refractory Differentiated Thyroid Cancers

  • Local Recurrence : Experience In Reirradiation And Brachytherapy

  • ImmunoOncology In Head & Neck Cancers

  • Precision Medicine : From Molecules To Optimizing Treatment In Clinical Practice

  • Molecular Profiling For Rare Cancers

  • Designing Phase I Clinical Trials And How It Benefits Patients

  • Treatment For Mrcc : Where Do We Fit Immunotherapy In Between Emerging Targeted Therapies?

  • Systemic Treatment For Ureteric And Bladder Cancers : From Chemotherapy To Immunotherapy

  • Clearing The Air For Systemic Treatment Sequence In Metastatic Hormone Sensitive And Hormone Refractory Prostate Cancer

  • Management Of Acute Oncology Emergencies

Comments are closed